[依折麦布与他汀类药物联合治疗相关的横纹肌溶解症] - Suppr

[Rhabdomyolysis associated to combined ezetimibe-statin treatment].

作者信息

Piedra León M, García Unzueta M T, Otero Martínez M, Amado Señaris J A

出版信息

Rev Clin Esp. 2007 Sep;207(8):425-6. doi: 10.1157/13108771.

DOI:10.1157/13108771

PMID:17688879

Abstract

摘要

相似文献

[Rhabdomyolysis associated to combined ezetimibe-statin treatment].

Rev Clin Esp. 2007 Sep;207(8):425-6. doi: 10.1157/13108771.

Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.

Atherosclerosis. 2012 Oct;224(2):454-6. doi: 10.1016/j.atherosclerosis.2012.07.036. Epub 2012 Aug 4.

Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.

J Clin Hypertens (Greenwich). 2009 Dec;11(12):766-8. doi: 10.1111/j.1559-4572.2009.00055.x.

The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.

Curr Med Res Opin. 2008 Mar;24(3):685-94. doi: 10.1185/030079908X273273. Epub 2008 Jan 25.

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

Int J Clin Pract. 2010 Jul;64(8):1052-61. doi: 10.1111/j.1742-1241.2010.02429.x. Epub 2010 May 12.

Risk factors for rhabdomyolysis with simvastatin and atorvastatin.

Drug Saf. 2006;29(12):1191; author reply 1191-2. doi: 10.2165/00002018-200629120-00009.

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.

Circulation. 2002 May 28;105(21):2469-75. doi: 10.1161/01.cir.0000018744.58460.62.

Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.

Am J Med. 2002 Apr 15;112(6):505. doi: 10.1016/s0002-9343(01)01135-4.

Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia.

Lipids Health Dis. 2009 Dec 17;8:56. doi: 10.1186/1476-511X-8-56.

Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.

JAAPA. 2012 Aug;25(8):30, 32-3. doi: 10.1097/01720610-201208000-00006.

引用本文的文献

Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report.

Front Oncol. 2022 Dec 14;12:1026434. doi: 10.3389/fonc.2022.1026434. eCollection 2022.

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Vasc Health Risk Manag. 2010 Nov 10;6:1023-37. doi: 10.2147/VHRM.S13496.

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Am J Cardiovasc Drugs. 2008;8(6):373-418. doi: 10.2165/0129784-200808060-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Rhabdomyolysis associated to combined ezetimibe-statin treatment].

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献